Design, Synthesis, and Biological Evaluation of Axitinib Derivatives

Wei, N; Liang, JQ; Peng, SM; Sun, Q; Dai, QY; Dong, MX

Peng, SM (reprint author), Xiangtan Univ, Dept Chem, Xiangtan 411105, Peoples R China.; Sun, Q; Dai, QY; Dong, MX (reprint author), Beijing Inst Biotechnol, Lab Prot Engn, Beijing 100071, Peoples R China.

MOLECULES, 2018; 23 (4):

Abstract

Axitinib is an approved kinase inhibitor for the therapy of advanced metastatic renal cell carcinoma (RCC). It prevents angiogenesis, cellular adhesio......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索